COMMUNIQUÉS West-GlobeNewswire

OneMedNet and Protege Partner to Advance the Future of AI-Driven Healthcare with Real-Time, Multimodal Data
23/04/2025
MINNEAPOLIS, April 23, 2025 (GLOBE NEWSWIRE) -- OneMedNet, a leader in AI-powered Real-World Data, has announced a strategic partnership with Protege, the AI training data platform, to enable real-time access, [...]
Hospice Choices: VITAS® Healthcare Expands in Austin, Texas
23/04/2025
AUSTIN, Texas, April 23, 2025 (GLOBE NEWSWIRE) -- Responding to the growing demand for high-quality hospice care in Central Texas, VITAS Healthcare has expanded its reach in the Austin area by opening a new [...]
VivoSim to Carry Forward Organovo 3D Bioprinting
23/04/2025
SAN DIEGO, April 23, 2025 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO) (the “Company”) announced that it will carry forward its 3D bioprinting and legacy technology as VivoSim Labs, Inc. A name change of [...]
Rezolute Announces Pricing of Offering of $90 Million of Common Stock and Pre-Funded Warrants
23/04/2025
NEW YORK, April 23, 2025 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage biopharmaceutical company committed to developing novel, transformative therapies for serious rare [...]
Phathom Pharmaceuticals to Report First Quarter 2025 Financial Results and Provide Business Update on Thursday, May 1, 2025
23/04/2025
• Management to host conference call on Thursday, May 1, 2025, at 8:00 am EDT FLORHAM PARK, N.J., April 23, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on [...]
Arialief Reviews And Complaints (INVESTIGATIVE REPORT) Safe Ingredients for Neuropathy Relief or Over Hype?
23/04/2025
MIAMI, April 23, 2025 (GLOBE NEWSWIRE) -- Arialief is a nerve-support supplement that has recently seen a rise in popularity. Like many dietary supplements aimed at relieving sciatic discomfort, it claims to deliver [...]
Rectify Pharma to Share Preclinical Data Highlighting Progress in Hepatobiliary Program at EASL 2025
23/04/2025
BOSTON, April 23, 2025 (GLOBE NEWSWIRE) -- Rectify Pharmaceuticals, Inc., (“Rectify”) a biotechnology company pioneering positive functional modulators (PFMs) that restore and enhance membrane protein function, today [...]
Daré Bioscience to Present at the Fierce Pharma Engage Summit on Breaking Barriers and Building Access: Communicating Bold Moves in Women’s Health Innovation
23/04/2025
Presentation will focus on corporate communications strategies for unveiling an innovative expanded business strategy Daré recently announced its new dual-path approach for its proprietary Sildenafil Cream formulation [...]
Protara Therapeutics to Host Conference Call and Webcast to Review Interim Data from Phase 2 ADVANCED-2 Trial of TARA-002 in Patients with NMIBC on Monday, April 28, 2025
23/04/2025
NEW YORK, April 23, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced it will [...]
Sagimet Biosciences Announces Upcoming Presentations at EASL Congress 2025
23/04/2025
SAN MATEO, Calif., April 23, 2025 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Sagimet, Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and [...]
Sanara MedTech to Report First Quarter 2025 Financial Results on May 14, 2025
23/04/2025
FORT WORTH, TX, April 23, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc . (“Sanara,” or the “Company”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to [...]
Akoya Biosciences and Singapore Translational Cancer Consortium (STCC) Partner on SUPER Study Designed to Advance Cancer Immunophenotyping for Patients in Singapore
23/04/2025
The STCC Unified PD1/PDL1 Evaluation of Response (SUPER) study is a multi-institutional study led by STCC with the goal of identifying predictors of PD1 immunotherapy response in an Asian real-world setting, bringing [...]
Plus Therapeutics Announces Biotech Industry Veteran Kyle Guse Joins its Board of Directors
23/04/2025
HOUSTON, April 23, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV ) (the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for [...]
UNITY Biotechnology Announces Publication in NEJM Evidence Highlighting the Potential of Senolytic Therapeutics to Provide Long-Term Improvements in Vision in DME
23/04/2025
SOUTH SAN FRANCISCO, Calif., April 23, 2025 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt or reverse diseases of aging, today [...]
Catheter Precision to Acquire Assets in Development for Late-Stage Treatment for Acute Decompensated Heart Failure
23/04/2025
Initial Clinical Studies Completed with Significant Positive Results The Cleveland Clinic Foundation, Abbott Laboratories and a New Era Associates (NEA) fund to Acquire Economic Interests in VTAK Fort Mill, S.C., April [...]
Recce Pharmaceuticals Receives Approval for Additional Phase II Trial of RECCE® 327 Topical Gel for Diabetic Foot Infections
23/04/2025
Human Research Ethics Committee (HREC) approval received to allow up to 20 additional patients access to RECCE ® 327 Topical Gel (R327G) treatment under existing open-label study protocol Program enables access to R327G [...]
Codetta Bio to Launch Concerto™ System at AACR 2025 with Exhibitor Spotlight Presentation
23/04/2025
DURHAM, N.C., April 23, 2025 (GLOBE NEWSWIRE) -- Codetta Bio , a leader in multi-omics innovation, today announced its presence at the American Association for Cancer Research (AACR) Annual Meeting 2025, where the [...]
Rhythm Pharmaceuticals to Report First Quarter 2025 Financial Results on Wednesday, May 7, 2025
23/04/2025
BOSTON, April 23, 2025 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine [...]
Beghou Consulting Prepares for Next Phase of Growth, Names Adrienne Lovink, Chief Services Officer, to Succeed Beth Beghou, Founder and CEO
23/04/2025
Adrienne Lovink to build on three decades of Beth Beghou’s transformative legacy, with a focus on maintaining best-in-class commercialization solutions while expanding technology- and AI-enabled capabilities EVANSTON, [...]

Pages